Back to Atlas
BSemi-durableStandard research/education caution
CMP-0195
Experimental
FOXO4-DRI
Senolytic / Longevity
Senescent-cell apoptosis positioning
Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.
Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.
Mechanism & Use
- Compound type
- Peptide
- Primary mechanism
- FOXO4-p53 interaction disruption
- Primary market use
- Longevity
Pharmacology
- Molecular weight (Da)
- ~5300
- Oral bioavailability
- N/A
- Half-life
- ~5–60 min parent peptide; analogs may be longer
- Route tags
- Route-dependent / verify
- Evidence level
- Preclinical
- Clinical status
- Experimental
- Value-for-money score
- 3 / 10
Reported protocol signal
No popular protocol verified yet; keep as reference compound until protocol signal is added.
For orientation only. See disclaimer — always consult a licensed clinician before use.
Notes
Potentially durable if senescent burden is reduced